Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» FDA staff backs Acadia's drug to treat psychosis associated with Parkinson's disease
FDA staff backs Acadia's drug to treat psychosis associated with Parkinson's disease
FDA staff backs Acadia's drug to treat psychosis associated with Parkinson's disease
Submitted by
admin
on March 25, 2016 - 9:37am
Source:
Yahoo/Reuters
News Tags:
FDA
Acadia
Parkinson's Disease Psychosis
Nuplazid
Headline:
FDA staff backs Acadia's drug to treat psychosis associated with Parkinson's disease
Do Not Allow Advertisers to Use My Personal information
